Art Rastinehad, DO, has been recognized as a 2026 Castle Connolly Top Doctor, marking the 12th year he has received this honor. The designation is awarded to only 7 percent of licensed physicians nationwide, based on peer nominations and selection by a physician-led research team. Dr. Rastinehad is professor of urology and radiology, vice chair of urology at Northwell's Lenox Hill Hospital, and Northwell Health System director for prostate cancer. His expertise spans precision prostate cancer diagnosis, MRI-targeted biopsy, focal therapy, image-guided treatment, interventional urology, and prostate artery embolization for enlarged prostate or benign prostatic hyperplasia (BPH).
"Being recognized as a Castle Connolly Top Doctor is meaningful because it reflects the trust patients and peers place in our work," said Dr. Rastinehad. "My goal is to help men make clear, informed decisions about prostate cancer, enlarged prostate, and urinary symptoms by coordinating the right evaluation and the most appropriate treatment options for each individual patient." He emphasizes a tailored approach, reviewing each patient's PSA history, MRI findings, biopsy results, prostate size, urinary symptoms, cancer risk, and personal goals before recommending a treatment path.
Dr. Rastinehad's research has significantly advanced image-guided prostate care. His team contributed to the early validation of MR/US fusion biopsy for prostate cancer detection in the United States. He was also the first dual fellowship-trained urologic oncologist and interventional radiologist, completing advanced training through the National Institutes of Health, the National Cancer Institute, and Northwell's North Shore University Hospital. This unique background allows him to integrate cancer surgery, advanced imaging, and minimally invasive image-guided therapy in one practice.
Key achievements include being part of the first team to publish a series on prostate artery embolization in 2006, early validation of MR/US fusion biopsy, and serving as principal investigator in the development of UroNav/Philips MR/US fusion technology for biopsy and focal therapy planning. He is a founding executive board member of the Focal Therapy Society and has over 20 years of experience in prostate artery embolization and interventional urology. His work continues to refine image-guided planning and annotation tools for focal therapy.
Dr. Rastinehad's practice at the urology department at Lenox Hill Hospital provides advanced prostate care for men with elevated PSA, abnormal prostate MRI, localized prostate cancer, enlarged prostate or BPH, urinary symptoms, and complex treatment decisions. The Castle Connolly Top Doctors list is published at castleconnolly.com and in various partner publications. Doctors do not and cannot pay to be selected.
